Daré Bioscience closes $975k Regulation A offering of Series A Preferred and warrants

Dare Bioscience, Inc.

Issued 195,010 Investor Units at $5.00 each, each unit consisting of one Series A Preferred share and two common stock warrants.
Total gross proceeds approximately $975,050 from closings on May 1,4,5,6, 2026.
Warrants to purchase up to 390,020 shares of common stock, terms as previously reported in Jan 29 2026 8-K.
Offering conducted under qualified Form 1-A (File No. 024-12688).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.